Antinociceptive and antiinflammatory activities of grandisin extracted from Virola surinamensis

Phytotherapy Research

Volumn 24, Issue 1, 2010, Pages 113-118

  Carvalho, Adryano A V ^a   Galdino, Pablinny M ^a   Nascimento, Marcus V M ^a   Kato, Massuo J ^b   Valadares, Marize C ^a   Cunha, Luiz C ^a   Costa, Elson A ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antinociceptive and antiinflammatory activity; Grandisin; Virola surinamensis

Indexed keywords

ACETIC ACID; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CARRAGEENAN; DEXAMETHASONE; DIAZEPAM; FORMALDEHYDE; GRANDISIN; INDOMETACIN; MORPHINE; NEOLIGNAN; OIL; PHENOBARBITAL; UNCLASSIFIED DRUG; VIROLA SURINAMENSIS EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG SCREENING; EAR; EDEMA; INFLAMMATION; LICKING; MALE; MOTOR COORDINATION; MOUSE; NEUROMODULATION; NONHUMAN; PAIN; SEDATION; WRITHING TEST;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FURANS; LIGNANS; MALE; MICE; MYRISTICACEAE; PAIN; PAIN MEASUREMENT; PLANT EXTRACTS;

MUS; MYRISTICACEAE; VIROLA SURINAMENSIS;

EID: 74249111425     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2882     Document Type: Article

References (29)

1. Archer J. 1973. Tests for emotionality in rats and mice: a review. Anim Behav 21: 205-235.
2. Ayres DC, Loike JD. 1990. Lignans Chemical and Clinical Properties. Cambridge University Press: Cambridge.
3. Bentley GA, Newton SH, Starr J. 1983. Studies on the antinociceptive action of against drugs and their interaction with opioid mechanisms. Br J Pharmacol 79: 125-134.
4. Brooks PM, Day RO. 1991. Nonsteroidal antiinflammatory drugs - differences and similarities. N Engl J Med 324: 1716-1725.
5. Calixto JB, Kassuya CAL, Silvestre AA, Rehder VLG. 2003. Antiallodynic and anti-oedematogenic properties of the extract and lignans from Phyllanthus amarus in models of persistent inflammatory and neuropathic pain. Eur J Pharmacol 478: 145-153.
6. Carlini EA, Burgos V. 1979. Screening farmacológico de ansiolíticos: Metodologia laboratorial e comparação entre diazepam e clorobenzepam. Rev Ass Bra Psiquiatria 1: 25-31.
7. Collier HOJ, Dinneen LC, Johnson CA, Schneider C. 1968. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol 32: 295-310.
8. Cunha FQ, Poole S, Lorenzetti BB, Feereira SH. 1992. The pivotal role of TNF-α in the development of inflammatory hyperalgesia. Br J Pharmacol 107: 660-669.
9. Dewick PM. 2002. Medicinal Natural Products: A Biosynthetic Approach, 2nd edn. John Wiley: Chichester, 130-142.
10. Di Vaio MAV, Freitas AC. 2001. Inflamação, tratamento e avanços recentes na terapia de doengas inflamatórias. Rev Cienc Saúde Biol 2: 37-69.
11. Duham NW, Miya TS. 1957. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 46: 208-209.
12. Ferrandiz ML, Alcaraz MJ. 1991. Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agents Actions 32: 283-288.
13. Hunskaar S, Fasmer OB, Hole K. 1985. Formalin test in mice, a useful technique for evaluating mild analgesics. J Neurosci Methods 14: 69-76.
14. Hunskaar S, Hole K. 1987. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30: 103-114.
15. Koster R, Andersons M, Debber EJ. 1959. Acetic acid analgesic screening. Fed Proc 18: 418-420.
16. Lancel M. 1999. Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists. Sleep 22: 33-42.
17. Liles WC, Van Voorhis WC. 1995. Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis 172: 1573-1580.
18. Lopes NP, Blumenthal EEA, Cavalheiro AJ, Kato MJ, Yoshida M. 1996. Lignans, γ-lactones and propiophenones of Virola surinamensis. Phytochemistry 43: 1089-1092.
19. Lopes NP, Chicaro P, Kato MJ, Albuquerque S, Yoshida M. 1998. Flavonoids and lignans from Virola surinamensis twigs and their in vitro activity against Trypanosoma cruzi. Planta Med 64: 667-669.
20. Lopes NP, Kato MJ, Andrade EHA et al. 1999. Antimalarial use of volatile oil from leaves of Virola surinamensis (Rol.) Warb. by Waiãpi Amazon Indians. J Ethnopharmacol 67: 313-319.
21. Rates SMK, Barros HMT. 1994. Modelos animais para a avaliaçã o dador: métodos para triagem de novos analgésicos. Rev Bras Farm 75: 31-34.
22. Rodrigues WA. 1980. Revisão taxonômica das espécies de Virola aublet (Myristicaceae) do Brasil. Acta Amazônica 10: 39-40.
23. Santos AR, Calixto JB. 1997. Further evidence for the involvement of tachykinin receptor subtypes in formalin and capsaicin models of pain in mice. Neuropeptides 31: 381-389.
24. Schultes RE, Holmstedt B. 1971. Miscellaneous notes on Myristicaceous plants of South America. Lloydia 34: 61-78.
25. Simões CMO, Schenkel EP, Gosmann G, Mello JCP, Mentz LA, Petrovick PR. 2004. Farmacognosia: da Planta ao Medicamento, 5th edn. Editora UFRGS: Porto Alegre.
26. Sokal RR, Rohlf FJ. 1981. Biometry: The Principles and Practice of Statistics in Biological Research, 2nd edn. WH Freeman & Co: New York, 859.
27. Tjølsen A, Hole K. 1997. Animals models of analgesia. In The Pharmacology of Pain, Dickenson AH, Besson JM (eds). Springer: Berlin, 1-20.
28. Tubaro A, Dri P, Delbello G, Silli C, Logia RD. 1985.The croton oil ear test revisited. Agents Actions 17: 47-49.
29. Vacher PJ, Duch́ene-Marullaz P, Barbot P. 1964. A propos de quelques produits usuels - comparaison de deux methodes d́tude des analgésiques. Med Exp 11: 51-58.